25316 Federal Register / Vol. 72, No. 86 / Friday, May 4, 2007 / Notices 

the services of a expert in dose 

reconstruction, an option provided for 

under 42 CFR § 83.9(c)(2)(iii). The 

petitioner would assume the financial 

burden of purchasing such services at 

their option. In such cases, HHS 

estimates a report by such an expert 

may cost between $640 and $6,400, 

depending on the scope of the petition 

and access to relevant information. This 

is based on an estimate of costs of $80 

per hour for contractual services by a 

health physicist, who NIOSH estimates 

would be employed within a range of 

eight to eighty hours to conduct and 

prepare a report on the required 

assessment. The total estimated 

annualized burden hours are 235. 

Estimate of Annualized Burden Hours 

Form name& number (CFR 

reference) Respondents Number of respondents 

Number of 

responses per 

respondent 

Average 

burden per 

respondent 

(in hours) 

83.9 ........................................ Petitioners using Form A ........................................................ 30 1 3/60 

83.9 ........................................ Petitioners using Form B ........................................................ 40 1 5 

83.9 ........................................ Petitioners not using Form B .................................................. 5 1 5.5 

83.18 ...................................... Petitioners Appealing proposed decisions .............................. 5 1 45/60 

Authorization Form ................. ................................................................................................. 20 1 3/60 

Dated: April 27, 2007. 

Maryam Daneshvar, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–8593 Filed 5–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[30Day–07–06BL] 

Agency Forms Undergoing Paperwork 

Reduction Act Review 

The Centers for Disease Control and 

Prevention (CDC) publishes a list of 

information collection requests under 

review by the Office of Management and 

Budget (OMB) in compliance with the 

Paperwork Reduction Act (44 U.S.C. 

Chapter 35). To request a copy of these 

requests, call the CDC Reports Clearance 

Officer at (404) 639–5960 or send an email to omb@cdc.gov. Send written 

comments to CDC Desk Officer, Office of 

Management and Budget, Washington, 

DC or by fax to (202) 395–6974. Written 

comments should be received within 30 

days of this notice. 

Proposed Project 

Examining the Efficacy of the HIV 

Testing Social Marketing Campaign for 

African American Women (HTSMC)— 

New—National Center for HIV/AIDS, 

Viral Hepatitis, STD, and TB Prevention 

(NCHHSTP), Coordinating Center for 

Infectious Diseases (CCID), Centers for 

Disease Control and Prevention (CDC). 

Background and Brief Description 

This project involves evaluation of the 

HIV Testing Social Marketing Campaign 

for African American Women (HTSMC), 

a CDC-sponsored social marketing 

campaign aimed at increasing HIV 

testing rates among young, single, 

African American women. The CDC has 

designed an efficacy study to evaluate 

the HTSMC and its messages under 

controlled conditions. The study entails 

selecting a sample of single African 

American females, ages 18 to 34, with 

less than 4 years of college education 

and collecting baseline data on their 

knowledge, attitudes, beliefs, intentions, 

and behaviors related to HIV testing. 

The study represents an ‘‘efficacy’’ 

methodology in that participants will be 

divided into treatment and control 

conditions. Participants in the treatment 

condition, will be exposed to campaign 

materials including radio 

advertisements, a billboard, and an 

informational booklet that will be 

distributed over the Internet. Thus the 

study participants’ exposure will occur 

under controlled conditions, without 

the distractions and variability of 

potential exposure in the real world. As 

part of the advertisement stimuli 

package, the billboard advertisement 

will appear as part of the online log-in 

for each stimuli session in order to 

simulate the appearance of a sign. 

Therefore, we do not estimate any 

additional burden for exposure to the 

billboard advertisement. 

Key outcomes related to the HTSMC 

will be measured in two follow-up 

surveys. The first follow-up survey will 

occur 2 weeks after the baseline survey. 

The second follow-up survey will occur 

6 weeks after the baseline survey. 

Comparisons of changes in these 

outcomes would then be made between 

participants in the treatment and control 

conditions. Findings from this study 

will be used by CDC and its partners to 

inform current and future program 

activities. 

We expect a total of 1630 participants 

to complete the baseline survey. The 

1630 participants who complete the 

baseline survey will be randomly 

assigned to the treatment or control 

condition. Eight hundred fifteen 

participants (the treatment condition) 

will be exposed to the radio ad and 

booklet. Of the 1630 participants who 

completed the baseline survey, we 

expect 1140 to complete the first followup survey. Of the 1140 who complete 

the first follow-up survey, we expect 

800 to complete the second follow-up 

survey, which will have fewer questions 

than the first follow-up survey because 

it will only pertain to questions about 

behavior change and selected behavioral 

intentions. 

There are no costs to the respondents 

other than their time. The total 

estimated annual burden hours are 

1,127. 

ESTIMATED ANNUALIZED BURDEN HOURS

Respondents Number of 

respondents 

Responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Study Screener ............................................................................................................................ 1630 1 2/60. 

Baseline survey ........................................................................................................................... 1630 1 13/60. 

Radio ad stimuli viewing .............................................................................................................. 815 1 12/60. 


cprice-sewell on DSK89S0YB1PROD with NOTICES
Federal Register / Vol. 72, No. 86 / Friday, May 4, 2007 / Notices 25317 

ESTIMATED ANNUALIZED BURDEN HOURS—Continued 

Respondents Number of 

respondents 

Responses 

per 

respondent 

Average 

burden per 

response 

(in hours) 

Booklet reading ............................................................................................................................ 815 1 15/60. 

Follow-Up survey 1 ...................................................................................................................... 1140 1 15/60. 

Follow-Up survey 2 ...................................................................................................................... 800 1 5/60. 

Dated: April 29, 2007. 

Joan F. Karr, 

Acting Reports Clearance Officer, Centers for 

Disease Control and Prevention. 

[FR Doc. E7–8641 Filed 5–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP) ‘‘Assessment of 

Proposed Revisions to the Youth 

Tobacco Survey: Impact on Measures 

of Youth Tobacco Use’’, Request for 

Applications (RFA) DP07–003 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces a meeting of the 

aforementioned SEP. 

Time and Date: 1 p.m.–3 p.m., June 7, 

2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to 

the public in accordance with 

provisions set forth in Section 552b(c) 

(4) and (6), Title 5 U.S.C., and the 

Determination of the Director, 

Management Analysis and Services 

Office, CDC, pursuant to Public Law 92– 

463. 

Matters To Be Discussed: The meeting 

will include the review, discussion, and 

evaluation of scientific merit of 

applications received in response to 

‘‘Assessment of Proposed Revisions to 

the Youth Tobacco Survey: Impact on 

Measures of Youth Tobacco Use,’’ RFA 

DP07–003. 

FOR FURTHER INFORMATION CONTACT: 

Denise Burton, Ph.D., Scientific Review 

Administrator, Office of the Chief 

Science Officer, CDC, 1600 Clifton 

Road, NE., Mailstop D72, Atlanta, GA 

30333, Telephone 404–639–4641. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: April 27, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. E7–8562 Filed 5–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel: Centers for Disease 

Control and Prevention (CDC) Grants 

for Public Health Research 

Dissertation, Program Announcement 

(PA) PAR–07–231 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention announces a 

meeting of the aforementioned Special 

Emphasis Panel. 

Times and Dates: 8 a.m.–5 p.m., June 14, 

2007 (Closed). 8:30 a.m.–5 p.m., June 15, 

2007 (Closed). 

Place: Doubletree Hotel Buckhead, 3342 

Peachtree Road NE, Atlanta, GA 30326, 

telephone 404–321–1234. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c) (4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘CDC Grants for Public Health 

Research Dissertation,’’ PA PAR–07–231. 

Contact Person For More Information: 

Juliana Cyril, Ph.D., M.P.H, Scientific Review 

Administrator, Office of the Chief Science 

Officer, CDC, 1600 Clifton Road NE., 

Mailstop D74, Atlanta, GA 30333, Telephone 

404–639–4639. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: April 27, 2007. 

Elaine L. Baker, 

Acting Director, Management Analysis and 

Services Office Centers for Disease Control 

and Prevention. 

[FR Doc. E7–8591 Filed 5–3–07; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Behavioral 

Assessments and Rapid HIV Testing 

Among African American Adolescents 

and Adults, Men Who Have Sex With 

Men and Other Groups at Risk for HIV 

Infection, Funding Opportunity 

Announcement (FOA) Number PS 07– 

001, and Rapid HIV Testing in 

Community Mental Health Settings 

Serving African Americans, FOA PS 

07–005 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting. 

Time and Date: 12:30 p.m.–4:30 p.m., May 

25, 2007 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters to be Discussed: The meeting will 

include the review, discussion, and 

evaluation of ‘‘Behavioral Assessments and 

Rapid HIV Testing Among African American 

Adolescents and Adults, Men Who Have Sex 

With Men and Other Groups at Risk for HIV 

Infection,’’ FOA Number PS 07–001, and 

‘‘Rapid HIV Testing in Community Mental 

Health Settings Serving African Americans,’’ 

FOA PS 07–005. 

Contact Person For More Information: J. 

Felix Rogers, Ph.D., M.P.H., Scientific 

Review Administrator, Extramural Research 

Program Office, Centers for Disease Control 

and Prevention, 1600 Clifton Road, NE, MS 


cprice-sewell on DSK89S0YB1PROD with NOTICES